Medicine’s Wild West — Unlicensed Stem-Cell Clinics in the United States.

Sep 11, 2015

Authors: Hermes Taylor-Weiner, Ph.D., and Joshua Graff Zivin, Ph.D.

Article in The New England Journal of Medicine. Perspective (September 10, 2015)

N Engl J Med 2015; 373:985-987 (DOI: 10.1056/NEJMp1504560).

In recent decades, there has been tremendous hope that stem-cell–based technologies would introduce a new era of regenerative medicine, revolutionizing the treatment of disease. These hopes have been stoked by reports that often emphasize promising findings without adequately acknowledging the many remaining challenges. Although stem-cell therapy may hold great potential, the field is less advanced than the public has been led to believe. Stem-cell clinics in the United States and abroad have capitalized on this confusion by selling treatments that are not approved by the Food and Drug Administration (FDA), supported by clinical studies, or covered by insurers.

More information here